A sensitive, accurate method has been established for the assay of serum carnosinase by measuring the fluorescence emitted from the L-histidine liberated on treatment with o-phthaldialdehyde. Using this method the serum values for normal adults, infants and children were measured. The mean value was very low in infants of less than 1 year old but increased with age, being almost the same in children aged 6 years or more as in adults. In adult men, the mean activity was 1·85 urnol/rnl.Zh and in adult women it was 2·07 umol/rnl.zh. Low activity was observed in patients with muscular dystrophy.
-Alanyl-histidine (carnosine), an uncommon dipeptide containing (3-amino acids, is widely and abundantly distributed in the body in organs such as muscle and kidney. But its exact distribution and its physiological function are unknown. The activity of camosinase, which catalyses the hydrolysis of carnosine to (3- alanine and L-histidine, has been measured by a microtitration method! developed by Grassman et al. in 1928. But, with this method, the amount of L-histidine produced by carnosinase from carnosine is too small to be measured accurately.
Murphey et al. 2 developed a new method in which L-histidine produced by carnosinase from carnosine is converted to a Schiff-base and the emitted fluorescence is measured with a fluorometer. In the present work we evaluated this method and modified it to make it more sensitive and precise. We then used it to measure the carnosinase acnvmes of normal subjects to obtain normal range of activities according to age and sex. We also examined the serum carnosinase activities of patients with myopathy.
Materials and methods
Carnosinase activity in serum is assayed by f1uorometric deterrninatiorr': 4 of the i-histidinc produced by incubating the serum with carnosine as a substrate, according to the method of Gerber. 3 The mechanism of formation of a histidine Schiff-base with o-phthaldialdehyde is shown in Fig .C
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SENSITIVITY OF THE ASSAY
Fluorescence intensity of the Schiff-base with o-phthaldialdehyde was proportional to the L-histidine concentration of the standard, as shown in Fig. 2 . Concentrations of 5-30 llg/mL of free L-histidine could be assayed by this method.
Results
CARNOSINASE ACTIVITY ASSAY
A sample of 150 ul, of serum was diluted with 150 ul, of cold 50 rnrnol/L Tris buffer solution (pH 8·4), and 100 ul, of diluted serum was preincubated 'with a mixture of 250 ul, of Tris buffer solution and 50 ul, of 20 mrnol/L MnCIz solution for 5 min at 37°C. Then 100 ul, of 50 mrnol/L carnosine solution was added. The mixtures were incubated at 37°C for 60 min and then 500 ul, of 10% trichloracetic acid solution was added. The mixture was centrifuged at 3000 rpm for 10 min to remove the precipitated proteins, and 100 ilL of the supernatant was mixed with 2 mL of 0·3 mol/L NaOH and 400 ul, of o-phthaldialdehyde solution (dissolved in 1% w/w dimethoxyethane) and allowed to stand at room temperature for 15 min. Then 400 ul, of 6 mol/L HCI was added, the mixture was shaken vigorously and the fluorescence was determined in a Shimazu-RF-510 fluorometer using excitation and emission wavelengths of 344 nm and 420 nm, respectively. A solution of 200 ug/rnl, t.-histidine in distilled water was stored at -20°C and used as standard. As a serum blank, the same volume of Tris buffer solution was added in place of carnosine solution. Carnosinase activity in serum was assayed in the following subjects: 120 normal adults (60 male and 60 female); 82 children of 0-11 years old, who were either healthy (56 subjects), or with mild complaints like common cold but without any other apparent physical abnormalities (26 cases); and 17 cases of progressive muscular dystrophy (12 of the Duchenne-type, two of the facio-scapulo-humeral type, two of congenital muscular dystrophy and one of congenital myopathy). Informed consent was obtained from control subjects or their mothers. carnosinase activities, the fluorescence intensity increased linearly for up to 90 min of incubation, and then tended to level off, as shown in Fig. 3 . Therefore, 60 min was chosen as the optimal incubation time. Blank values may be determined from histidine contained in carnosine and serum.
Next we examined the effect of pH by varying the pH of Tris buffer solution from 7·5 to 9·5, for the assay of carnosinase activity. The activity was maximum at pH 8·4. The K m value for carnosine was determined using concentration of carnosine of 1 to 20 mmol. From the Lineweaver-Burk plot of these data, as shown in Fig. 4 , the K m value was calculated as 5 mmol.
PRECISION AND ACCURACY OF THE ASSAY
With this assay procedure, the mean intra-assay coefficient of variation (CY) for 10 replicate 1·0 samples was 3·3%, and the inter-assay CY, determined by assays on four samples five times, was 4·8% (Table 1) . The recovery rate determined by adding 15 ug/rnl, of L-histidine to 10 samples, was 98·6 ± 6·6% (mean ± SD).
SERUM CARNOSINASE ACTIVITY LEVELS
The statistical distribution for serum carnosinase activity in normal adults showed a normal distribution. The value was 1·85±0·59 (mean±SD) umol/mlzh (n=60) for adult men and 2·07±0·64 umol/rnlzh (n=60) for adult women. Thus there was no significant sex difference ( Table 2) .
The serum carnosinase activity was very low in control infants aged under 1 year: 0·14±0·07 umol/rnlzh (n=7) in boys and 0·22±0·15 urnol/ mUh (n=8) in girls. The activity increased with age and it was almost the same in children aged 6 years or more as in adults ( The serum activities of carnosinase were significantly lower than normal in patients with various types of muscular dystrophy. However, no correlation was observed between the carnosinase activity and other muscle-related activities in these patients (Table 3) .
Discussion
In 1967, Perry et al." first reported a case of carnosinase deficiency. Since then, 11 patients with carnosinase deficiency including variant forms have been reported.P" All of them had symptoms of the central nervous system, such as intermittent seizures, psychomotor attacks or mental retardation.
The amount of carnosine in normal muscle is reported to be 100 times that in blood, but carnosinase activity is low in muscle for some unknown reason. It has been suggested that the metabolism of carnosine is disturbed in muscular diseases.": 10 Carnosinase activity has been measured by detecting the production of L-histidine from carnosine with an amino-acid analyser.?"!' but the sensitivity of this method is very low and an incubation time of more than 12 hours is required to obtain a measurable amount of L-histidine. Later a fluorometric method was developed, but it also required a long incubation time, more than 2 hours.
In the present study, we developed a new highly sensitive and precise fluorometric procedure for detecting trace amounts of L-histidine during a 60-min incubation period. Various amino acids form fluorescent compounds with o-phthaldialdehyde, but in the procedure described here, only L-histidine, which has a 3-hydroxy base, formed a fluorescent compound under alkaline conditions. Manganese and cadmium are reported to be effective as the activating metal ions, and cadmium is a more potent activator than manganese;" but we observed that manganese was more suitable than cadmium under the present conditions. Moreover, a very high concentration of substrate, carnosine, did not interfere with the enzyme activity.
In the present study, we found that patients with progressive muscular dystrophy or myopathy had very low serum carnosinase activity. Significantly low serum carnosinase activity has been reportedv 5 in some disorders of the central nervous system and in muscle diseases. The pathophysiological role of this enzyme in these diseases requires further study.
